Antibacterial activity of synthetic human B defensin-2 against periodontal bacteria.

Fumi Mineshiba, Shogo Takashiba, Junji Mineshiba, Kaori Matsuura, Susumu Kokeguchi, Yoji Murayama

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

The oral epithelium is continuously exposed to a variety of microbial challenges that can cause infectious diseases such as periodontal disease. Human B Defensin-2 (hBD-2) is a cationic antimicrobial peptide with low molecular weight, which is inducible from oral epithelial cells upon either bacterial infection or stimulation with inflammatory cytokines. This peptide has a broad antimicrobial spectrum that includes gram-positive bacteria, gram-negative bacteria, and fungi. Therefore, it is thought that hBD-2 plays an important role as one of natural immunities to bacterial infection. However, its activity is inhibited by body fluids such as serum. The aim of this study was to assess the antibacterial activity of synthetic hBD-2 against oral bacteria in the presence of saliva or serum. The antibacterial activity of synthetic hBD-2 was tested against Actinobacillus actinomycetemcomitans, Porphyromonas gingivalis, Streptococcus mutans, and Escherichia coli. Antibacterial broth assay and diffusion assay were performed in vitro. The antibacterial activity of hBD-2 was approximately equal to that of minocycline at equimolar concentrations. Furthermore, the activity of hBD-2 remained at 60% in the presence of 80% saliva, whereas no activity remained in the presence of 20% serum. Our results suggest the possibility that synthetic hBD-2 could be useful to prevent infection by periodontal bacteria.

Original languageEnglish
Pages (from-to)35-40
Number of pages6
JournalJournal of the International Academy of Periodontology
Volume5
Issue number2
Publication statusPublished - 2003

Fingerprint

Defensins
Human Activities
Bacteria
Saliva
Bacterial Infections
Serum
Antimicrobial Cationic Peptides
Aggregatibacter actinomycetemcomitans
Porphyromonas gingivalis
Minocycline
Streptococcus mutans
Gram-Positive Bacteria
Periodontal Diseases
Body Fluids
Gram-Negative Bacteria
Innate Immunity
Communicable Diseases
Fungi
Epithelium
Molecular Weight

Cite this

Antibacterial activity of synthetic human B defensin-2 against periodontal bacteria. / Mineshiba, Fumi; Takashiba, Shogo; Mineshiba, Junji; Matsuura, Kaori; Kokeguchi, Susumu; Murayama, Yoji.

In: Journal of the International Academy of Periodontology, Vol. 5, No. 2, 2003, p. 35-40.

Research output: Contribution to journalArticle

@article{f69fb8d4bdc243dfa13cb75a425d3dd3,
title = "Antibacterial activity of synthetic human B defensin-2 against periodontal bacteria.",
abstract = "The oral epithelium is continuously exposed to a variety of microbial challenges that can cause infectious diseases such as periodontal disease. Human B Defensin-2 (hBD-2) is a cationic antimicrobial peptide with low molecular weight, which is inducible from oral epithelial cells upon either bacterial infection or stimulation with inflammatory cytokines. This peptide has a broad antimicrobial spectrum that includes gram-positive bacteria, gram-negative bacteria, and fungi. Therefore, it is thought that hBD-2 plays an important role as one of natural immunities to bacterial infection. However, its activity is inhibited by body fluids such as serum. The aim of this study was to assess the antibacterial activity of synthetic hBD-2 against oral bacteria in the presence of saliva or serum. The antibacterial activity of synthetic hBD-2 was tested against Actinobacillus actinomycetemcomitans, Porphyromonas gingivalis, Streptococcus mutans, and Escherichia coli. Antibacterial broth assay and diffusion assay were performed in vitro. The antibacterial activity of hBD-2 was approximately equal to that of minocycline at equimolar concentrations. Furthermore, the activity of hBD-2 remained at 60{\%} in the presence of 80{\%} saliva, whereas no activity remained in the presence of 20{\%} serum. Our results suggest the possibility that synthetic hBD-2 could be useful to prevent infection by periodontal bacteria.",
author = "Fumi Mineshiba and Shogo Takashiba and Junji Mineshiba and Kaori Matsuura and Susumu Kokeguchi and Yoji Murayama",
year = "2003",
language = "English",
volume = "5",
pages = "35--40",
journal = "Journal of the International Academy of Periodontology",
issn = "1466-2094",
publisher = "FDI World Dental Press Ltd",
number = "2",

}

TY - JOUR

T1 - Antibacterial activity of synthetic human B defensin-2 against periodontal bacteria.

AU - Mineshiba, Fumi

AU - Takashiba, Shogo

AU - Mineshiba, Junji

AU - Matsuura, Kaori

AU - Kokeguchi, Susumu

AU - Murayama, Yoji

PY - 2003

Y1 - 2003

N2 - The oral epithelium is continuously exposed to a variety of microbial challenges that can cause infectious diseases such as periodontal disease. Human B Defensin-2 (hBD-2) is a cationic antimicrobial peptide with low molecular weight, which is inducible from oral epithelial cells upon either bacterial infection or stimulation with inflammatory cytokines. This peptide has a broad antimicrobial spectrum that includes gram-positive bacteria, gram-negative bacteria, and fungi. Therefore, it is thought that hBD-2 plays an important role as one of natural immunities to bacterial infection. However, its activity is inhibited by body fluids such as serum. The aim of this study was to assess the antibacterial activity of synthetic hBD-2 against oral bacteria in the presence of saliva or serum. The antibacterial activity of synthetic hBD-2 was tested against Actinobacillus actinomycetemcomitans, Porphyromonas gingivalis, Streptococcus mutans, and Escherichia coli. Antibacterial broth assay and diffusion assay were performed in vitro. The antibacterial activity of hBD-2 was approximately equal to that of minocycline at equimolar concentrations. Furthermore, the activity of hBD-2 remained at 60% in the presence of 80% saliva, whereas no activity remained in the presence of 20% serum. Our results suggest the possibility that synthetic hBD-2 could be useful to prevent infection by periodontal bacteria.

AB - The oral epithelium is continuously exposed to a variety of microbial challenges that can cause infectious diseases such as periodontal disease. Human B Defensin-2 (hBD-2) is a cationic antimicrobial peptide with low molecular weight, which is inducible from oral epithelial cells upon either bacterial infection or stimulation with inflammatory cytokines. This peptide has a broad antimicrobial spectrum that includes gram-positive bacteria, gram-negative bacteria, and fungi. Therefore, it is thought that hBD-2 plays an important role as one of natural immunities to bacterial infection. However, its activity is inhibited by body fluids such as serum. The aim of this study was to assess the antibacterial activity of synthetic hBD-2 against oral bacteria in the presence of saliva or serum. The antibacterial activity of synthetic hBD-2 was tested against Actinobacillus actinomycetemcomitans, Porphyromonas gingivalis, Streptococcus mutans, and Escherichia coli. Antibacterial broth assay and diffusion assay were performed in vitro. The antibacterial activity of hBD-2 was approximately equal to that of minocycline at equimolar concentrations. Furthermore, the activity of hBD-2 remained at 60% in the presence of 80% saliva, whereas no activity remained in the presence of 20% serum. Our results suggest the possibility that synthetic hBD-2 could be useful to prevent infection by periodontal bacteria.

UR - http://www.scopus.com/inward/record.url?scp=0141989195&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0141989195&partnerID=8YFLogxK

M3 - Article

VL - 5

SP - 35

EP - 40

JO - Journal of the International Academy of Periodontology

JF - Journal of the International Academy of Periodontology

SN - 1466-2094

IS - 2

ER -